Richard S. Creager
Directeur Général chez Seegene USA, Inc.
Profil
Richard S.
Creager is currently the Chief Executive Officer at Seegene USA, Inc. He is also a Director at Rosalind, Inc., LifeScience Alley, and Seraph Biosciences, Inc. Additionally, he is a Director at Ubiquitome Ltd.
Dr. Creager has previously worked as a Director at ProteoGenix, Inc. and as a Group Vice President-High Sensitivity Testing at Beckman Coulter, Inc. He holds a doctorate degree from the University of Pittsburgh School of Medicine.
Postes actifs de Richard S. Creager
| Sociétés | Poste | Début |
|---|---|---|
LifeScience Alley
 LifeScience Alley Miscellaneous Commercial ServicesCommercial Services LifeScience Alley provides access to industry leaders, opportunities to build business through education and networking, insights into current trends, regulations, research and emerging technologies. The private company is based in St. Louis Park, MN. Shaye R. Mandle has been the CEO of the company since 2011. | Directeur/Membre du Conseil | - |
Ubiquitome Ltd.
 Ubiquitome Ltd. Electronic Equipment/InstrumentsElectronic Technology Ubiquitome Ltd. engages in development and provision of cloud solutions for clinical, environmental, conservation, and forensic applications. The company was founded by Paul Pickering and is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | 29/08/2019 |
Rosalind, Inc.
 Rosalind, Inc. Packaged SoftwareTechnology Services Onramp Bioinformatics, Inc. develops bioinformatics solutions for genomics analysis. Its software solutions provide computational analysis and storage services for pharmaceuticals, clinicians, researchers, sequence service providers, and biotechnology professionals. The company was founded by Tim Wesselman in 2013 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Seraph Biosciences, Inc.
 Seraph Biosciences, Inc. Medical SpecialtiesHealth Technology Seraph Biosciences, Inc. develops Raman Spectroscopy that operates as a equipment for real-time pathogen detection and point of care. The company was founded by Charles Shanley, Gregor Auner, and Mark Trexler and is headquartered in Detroit, MI. | Directeur/Membre du Conseil | - |
| Seegene USA, Inc. | Directeur Général | 02/03/2022 |
Anciens postes connus de Richard S. Creager
| Sociétés | Poste | Fin |
|---|---|---|
ProteoGenix, Inc.
 ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Directeur/Membre du Conseil | 29/03/2012 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Corporate Officer/Principal | - |
Formation de Richard S. Creager
| University of Pittsburgh School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Health Technology |
LifeScience Alley
LifeScience Alley Miscellaneous Commercial ServicesCommercial Services LifeScience Alley provides access to industry leaders, opportunities to build business through education and networking, insights into current trends, regulations, research and emerging technologies. The private company is based in St. Louis Park, MN. Shaye R. Mandle has been the CEO of the company since 2011. | Commercial Services |
ProteoGenix, Inc.
ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Health Technology |
Ubiquitome Ltd.
Ubiquitome Ltd. Electronic Equipment/InstrumentsElectronic Technology Ubiquitome Ltd. engages in development and provision of cloud solutions for clinical, environmental, conservation, and forensic applications. The company was founded by Paul Pickering and is headquartered in Auckland, New Zealand. | Electronic Technology |
Rosalind, Inc.
Rosalind, Inc. Packaged SoftwareTechnology Services Onramp Bioinformatics, Inc. develops bioinformatics solutions for genomics analysis. Its software solutions provide computational analysis and storage services for pharmaceuticals, clinicians, researchers, sequence service providers, and biotechnology professionals. The company was founded by Tim Wesselman in 2013 and is headquartered in San Diego, CA. | Technology Services |
Seraph Biosciences, Inc.
Seraph Biosciences, Inc. Medical SpecialtiesHealth Technology Seraph Biosciences, Inc. develops Raman Spectroscopy that operates as a equipment for real-time pathogen detection and point of care. The company was founded by Charles Shanley, Gregor Auner, and Mark Trexler and is headquartered in Detroit, MI. | Health Technology |
| Seegene USA, Inc. |
